SCHEMBL21628489

SCHEMBL21628489

CN(C)C(=O)c1ccc(Oc2ccc(C3CC3)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.71
ALDH1A1 P00352 2/20 0.71
SMN1; SMN2 Q16637 2/20 0.71
MMP13 P45452 1/20 0.47
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
PARP10 Q53GL7 1/20 0.44
STAT3 P40763 4/20 0.43
MAPT P10636 2/20 0.43
RAB9A P51151 1/20 0.43
USP30 Q70CQ3 1/20 0.42
GPR119 Q8TDV5 2/20 0.41
MMP14 P50281 1/20 0.41
HDAC1 Q13547 1/20 0.41
HSD17B1 P14061 2/20 0.40
HSD17B2 P37059 2/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21628688 0.94 ALDH1A1 (0.67) HPGDALDH1A1SMN1; SMN2MMP13MEN1
SCHEMBL21628904 0.94 ALDH1A1 (0.67) HPGDALDH1A1SMN1; SMN2MMP13MEN1
SCHEMBL21628651 0.92 ALDH1A1 (0.65) HPGDALDH1A1SMN1; SMN2MMP13MEN1
SCHEMBL21628738 0.92 ALDH1A1 (0.65) HPGDALDH1A1SMN1; SMN2MMP13MEN1
SCHEMBL21628747 0.83 SMN1; SMN2 (0.49) HPGDALDH1A1SMN1; SMN2
SCHEMBL21628619 0.82 ALDH1A1 (0.48) HPGDALDH1A1SMN1; SMN2SLC6A2SLC6A4
SCHEMBL21274803 0.80 PARP10 (0.56) HPGDALDH1A1KMT2APARP10MAPT
SCHEMBL744509 0.79 ESR2 (0.56) HPGDALDH1A1SMN1; SMN2SLC6A2SLC6A4
SCHEMBL21288239 0.79 CA1 (0.55) HPGDALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL31700659 0.79 LIMK2 (0.49) HPGDALDH1A1SMN1; SMN2USP30CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2022-11-03 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK HPGD 2579/4885ALDH1A1 717/4885SMN1; SMN2 796/4885
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK HPGD 2579/4885ALDH1A1 717/4885SMN1; SMN2 796/4885
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK HPGD 2313/4885ALDH1A1 900/4885SMN1; SMN2 1107/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK HPGD 2579/4885ALDH1A1 717/4885SMN1; SMN2 796/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR HPGD 3694/4885ALDH1A1 929/4885SMN1; SMN2 919/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK HPGD 2579/4885ALDH1A1 717/4885SMN1; SMN2 796/4885
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK HPGD 2579/4885ALDH1A1 717/4885SMN1; SMN2 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.